{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T19:35:32Z","timestamp":1757619332941,"version":"3.44.0"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2025,7,18]],"date-time":"2025-07-18T00:00:00Z","timestamp":1752796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2025,7,18]],"date-time":"2025-07-18T00:00:00Z","timestamp":1752796800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/501100022606","name":"Almirall","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100022606","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dermatol Ther (Heidelb)"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1007\/s13555-025-01499-8","type":"journal-article","created":{"date-parts":[[2025,7,18]],"date-time":"2025-07-18T08:36:54Z","timestamp":1752827814000},"page":"2645-2656","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Well-Being in Psoriasis: Weighting its Components Using Best-worst Scaling Methodology"],"prefix":"10.1007","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0676-1260","authenticated-orcid":false,"given":"Esteban","family":"Daud\u00e9n","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6007-7320","authenticated-orcid":false,"given":"Isabel","family":"Belinch\u00f3n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6835-2868","authenticated-orcid":false,"given":"Elena","family":"Colominas-Gonz\u00e1lez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pablo","family":"Coto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4807-3551","authenticated-orcid":false,"given":"Pablo","family":"de la Cueva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8996-3828","authenticated-orcid":false,"given":"Fernando","family":"Gallardo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1800-6198","authenticated-orcid":false,"given":"Jose Luis","family":"Poveda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3053-7426","authenticated-orcid":false,"given":"Esther","family":"Ram\u00edrez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6267-1059","authenticated-orcid":false,"given":"Sandra","family":"Ros","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0381-6174","authenticated-orcid":false,"given":"Ricardo","family":"Ru\u00edz-Villaverde","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-8726-9913","authenticated-orcid":false,"given":"Isabel","family":"Cabezas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6039-2454","authenticated-orcid":false,"given":"Luis","family":"Liz\u00e1n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,7,18]]},"reference":[{"issue":"6","key":"1499_CR1","doi-asserted-by":"publisher","first-page":"1475","DOI":"10.3390\/ijms20061475","volume":"20","author":"A Rendon","year":"2019","unstructured":"Rendon A, Schakel K. Psoriasis pathogenesis and treatment. Int J Mol Sci. 2019;20(6):1475.","journal-title":"Int J Mol Sci"},{"issue":"4","key":"1499_CR2","volume":"15","author":"A Hepat","year":"2023","unstructured":"Hepat A, Chakole S, Rannaware A. Psychological well-being of adult psoriasis patients: a narrative review. Cureus. 2023;15(4): e37702.","journal-title":"Cureus"},{"issue":"1","key":"1499_CR3","doi-asserted-by":"publisher","first-page":"T33","DOI":"10.1016\/j.ad.2022.07.025","volume":"114","author":"K Nabieva","year":"2023","unstructured":"Nabieva K, Vender R. Quality of life and body region affected by psoriasis: a systematic review. Actas Dermosifiliogr. 2023;114(1):T33\u20138.","journal-title":"Actas Dermosifiliogr"},{"issue":"5","key":"1499_CR4","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/j.ad.2020.11.017","volume":"112","author":"L Puig","year":"2021","unstructured":"Puig L, et al. Burden of psoriasis in catalonia: epidemiology, associated comorbidities, health care utilization, and sick leave. Actas Dermosifiliogr (Engl Ed). 2021;112(5):425\u201333.","journal-title":"Actas Dermosifiliogr (Engl Ed)"},{"issue":"4","key":"1499_CR5","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1586\/14737167.2014.914437","volume":"14","author":"M Augustin","year":"2014","unstructured":"Augustin M, Radtke MA. Quality of life in psoriasis patients. Expert Rev Pharmacoecon Outcomes Res. 2014;14(4):559\u201368.","journal-title":"Expert Rev Pharmacoecon Outcomes Res"},{"issue":"2","key":"1499_CR6","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1007\/s13555-021-00669-8","volume":"12","author":"B Kowalewska","year":"2022","unstructured":"Kowalewska B, Krajewska-Kulak E, Sobolewski M. The impact of stress-coping strategies and the severity of psoriasis on self-esteem, illness acceptance and life satisfaction. Dermatol Ther (Heidelb). 2022;12(2):529\u201343.","journal-title":"Dermatol Ther (Heidelb)"},{"issue":"2","key":"1499_CR7","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.ad.2013.02.009","volume":"105","author":"S Ros","year":"2014","unstructured":"Ros S, Puig L, Carrascosa JM. Cumulative life course impairment: the imprint of psoriasis on the patient\u2019s life. Actas Dermosifiliogr. 2014;105(2):128\u201334.","journal-title":"Actas Dermosifiliogr"},{"issue":"3","key":"1499_CR8","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1007\/s12529-022-10104-7","volume":"30","author":"AM Snyder","year":"2023","unstructured":"Snyder AM, et al. Quality of life among family of patients with atopic dermatitis and psoriasis. Int J Behav Med. 2023;30(3):409\u201315.","journal-title":"Int J Behav Med"},{"issue":"1","key":"1499_CR9","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.pbj.2016.11.003","volume":"2","author":"S Pinto","year":"2017","unstructured":"Pinto S, et al. Comfort, well-being and quality of life: discussion of the differences and similarities among the concepts. Porto Biomed J. 2017;2(1):6\u201312.","journal-title":"Porto Biomed J"},{"key":"1499_CR10","doi-asserted-by":"publisher","first-page":"50","DOI":"10.4321\/S0213-61632014000100005","volume":"28","author":"L Salvador-Carulla","year":"2014","unstructured":"Salvador-Carulla L, et al. Use of the terms \u201cWellbeing\u201d and \u201cQuality of life\u201d in health sciences: a conceptual framework. Eur J Psychiat. 2014;28:50\u201365.","journal-title":"Eur. J. Psychiat"},{"issue":"1","key":"1499_CR11","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1186\/s12955-020-01423-y","volume":"18","author":"K Ruggeri","year":"2020","unstructured":"Ruggeri K, et al. Well-being is more than happiness and life satisfaction: a multidimensional analysis of 21 countries. Health Qual Life Outcomes. 2020;18(1):192.","journal-title":"Health Qual Life Outcomes"},{"issue":"7","key":"1499_CR12","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1007\/s40273-016-0389-9","volume":"34","author":"M Karimi","year":"2016","unstructured":"Karimi M, Brazier J. Health, health-related quality of life, and quality of life: what is the difference? Pharmacoeconomics. 2016;34(7):645\u20139.","journal-title":"Pharmacoeconomics"},{"key":"1499_CR13","first-page":"117","volume":"15","author":"M Naughton","year":"1996","unstructured":"Naughton M, Shumaker S, Anderson R, Czajkowski S. Psychological aspects of health-related quality of life measurement: test and scales. Qual Life Pharmaco Econ Clin Trials. 1996;15:117\u201331.","journal-title":"Qual Life Pharmaco Econ Clin Trials"},{"issue":"2","key":"1499_CR14","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1111\/jdv.19567","volume":"38","author":"R Sommer","year":"2024","unstructured":"Sommer R, et al. Implementing well-being in the management of psoriasis: An expert recommendation. J Eur Acad Dermatol Venereol. 2024;38(2):302\u201310.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"4","key":"1499_CR15","doi-asserted-by":"publisher","DOI":"10.1111\/nmo.14531","volume":"35","author":"EN Madva","year":"2023","unstructured":"Madva EN, et al. Positive psychological well-being: a novel concept for improving symptoms, quality of life, and health behaviors in irritable bowel syndrome. Neurogastroenterol Motil. 2023;35(4): e14531.","journal-title":"Neurogastroenterol Motil"},{"issue":"3","key":"1499_CR16","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1684\/ejd.2020.3768","volume":"30","author":"N da Silva","year":"2020","unstructured":"da Silva N, et al. Disease burden and treatment needs of patients with psoriasis in sexually-sensitive and visible body areas: results from a large-scale survey in routine care. Eur J Dermatol. 2020;30(3):267\u201378.","journal-title":"Eur J Dermatol"},{"issue":"1","key":"1499_CR17","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1186\/s12888-023-05321-7","volume":"23","author":"A Orzechowska","year":"2023","unstructured":"Orzechowska A, et al. Emotional control in selected somatic and psychiatric diseases. BMC Psychiatry. 2023;23(1):802.","journal-title":"BMC Psychiatry"},{"key":"1499_CR18","unstructured":"Sommer, R., Patient-reported well-being using tildrakizumab in a real-world setting: 28-week interim data of the phase IV POSITIVE study. Presented at the 32nd European academy of dermatology and venereology (EADV) congress, 2023, Berlin, Germany. Abstract 3490. 2023"},{"issue":"6","key":"1499_CR19","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.1111\/bjd.20568","volume":"185","author":"K Reich","year":"2021","unstructured":"Reich K, et al. Five-year maintenance of clinical response and health-related quality of life improvements in patients with moderate-to-severe psoriasis treated with guselkumab: results from VOYAGE 1 and VOYAGE 2. Br J Dermatol. 2021;185(6):1146\u201359.","journal-title":"Br J Dermatol"},{"issue":"1","key":"1499_CR20","doi-asserted-by":"publisher","first-page":"14519","DOI":"10.1038\/s41598-024-64738-6","volume":"14","author":"E Dauden","year":"2024","unstructured":"Dauden E, et al. Defining well-being in psoriasis: a Delphi consensus among healthcare professionals and patients. Sci Rep. 2024;14(1):14519.","journal-title":"Sci Rep"},{"issue":"12","key":"1499_CR21","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1007\/s40273-016-0429-5","volume":"34","author":"KL Cheung","year":"2016","unstructured":"Cheung KL, et al. using best-worst scaling to investigate preferences in health care. Pharmacoeconomics. 2016;34(12):1195\u2013209.","journal-title":"Pharmacoeconomics"},{"issue":"9","key":"1499_CR22","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1007\/s40273-022-01167-1","volume":"40","author":"IL Hollin","year":"2022","unstructured":"Hollin IL, et al. Best-worst scaling and the prioritization of objects in health: a systematic review. Pharmacoeconomics. 2022;40(9):883\u201399.","journal-title":"Pharmacoeconomics"},{"issue":"1","key":"1499_CR23","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s13561-015-0079-x","volume":"6","author":"AC Muhlbacher","year":"2016","unstructured":"Muhlbacher AC, et al. Experimental measurement of preferences in health and healthcare using best-worst scaling: an overview. Health Econ Rev. 2016;6(1):2.","journal-title":"Health Econ Rev"},{"key":"1499_CR24","unstructured":"Lancsar, E. and J.J. Louviere, Estimating individual level discrete choice models and welfare measures using best worst choice experiments and sequential best worst MNL. Sydney: University of Technology, Centre for the Study of Choice (Censoc), 2008: p. 1\u201324."},{"issue":"4","key":"1499_CR25","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/S0950-3293(01)00022-2","volume":"12","author":"IN Wakeling","year":"2001","unstructured":"Wakeling IN, Buck D. Balanced incomplete block designs useful for consumer experimentation. Food Qual Prefer. 2001;12(4):265\u20138.","journal-title":"Food Qual Prefer"},{"issue":"2","key":"1499_CR26","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0189687","volume":"13","author":"EJB Uy","year":"2018","unstructured":"Uy EJB, et al. Using best-worst scaling choice experiments to elicit the most important domains of health for health-related quality of life in Singapore. PLoS ONE. 2018;13(2): e0189687.","journal-title":"PLoS ONE"},{"issue":"7","key":"1499_CR27","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1001\/jamadermatol.2020.1054","volume":"156","author":"C Read","year":"2020","unstructured":"Read C, Armstrong AW. Association between the mental health of patients with psoriasis and their satisfaction with physicians. JAMA Dermatol. 2020;156(7):754\u201362.","journal-title":"JAMA Dermatol"},{"key":"1499_CR28","doi-asserted-by":"publisher","first-page":"adv6485","DOI":"10.2340\/actadv.v103.6485","volume":"103","author":"S Van Beugen","year":"2023","unstructured":"Van Beugen S, et al. Perceived stigmatization among dermatological outpatients compared with controls: an observational multicentre study in 17 european countries. Acta Derm Venereol. 2023;103:adv6485.","journal-title":"Acta Derm Venereol"},{"issue":"2","key":"1499_CR29","first-page":"237","volume":"179","author":"K Montgomery","year":"2018","unstructured":"Montgomery K, Thompson AR. Developing sensitivity to the psychological burden associated with skin conditions: a call for training. Br J Dermatol. 2018;179(2):237\u20138.","journal-title":"Br J Dermatol"},{"issue":"1","key":"1499_CR30","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1111\/j.1468-3083.2011.04000.x","volume":"26","author":"TM Ljosaa","year":"2012","unstructured":"Ljosaa TM, et al. Skin pain and skin discomfort is associated with quality of life in patients with psoriasis. J Eur Acad Dermatol Venereol. 2012;26(1):29\u201335.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"2","key":"1499_CR31","doi-asserted-by":"publisher","first-page":"175","DOI":"10.2340\/00015555-3065","volume":"99","author":"K Kaaz","year":"2019","unstructured":"Kaaz K, Szepietowski JC, Matusiak L. Influence of itch and pain on sleep quality in atopic dermatitis and psoriasis. acta Derm Venereol. 2019;99(2):175\u201380.","journal-title":"acta Derm Venereol"},{"issue":"5","key":"1499_CR32","doi-asserted-by":"publisher","first-page":"299","DOI":"10.5114\/pdia.2014.40927","volume":"31","author":"A Ograczyk","year":"2014","unstructured":"Ograczyk A, et al. Itch, disease coping strategies and quality of life in psoriasis patients. Postepy Dermatol Alergol. 2014;31(5):299\u2013304.","journal-title":"Postepy Dermatol Alergol"},{"key":"1499_CR33","first-page":"41","volume":"8","author":"EJ Yang","year":"2018","unstructured":"Yang EJ, et al. The impact of genital psoriasis on quality of life: a systematic review. Psoriasis (Auckl). 2018;8:41\u20137.","journal-title":"Psoriasis (Auckl)"},{"issue":"2","key":"1499_CR34","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1007\/s13555-021-00662-1","volume":"12","author":"J Nowowiejska","year":"2022","unstructured":"Nowowiejska J, et al. Assessment of life quality, stress and physical activity among patients with psoriasis. Dermatol Ther (Heidelb). 2022;12(2):395\u2013406.","journal-title":"Dermatol Ther (Heidelb)"},{"issue":"6","key":"1499_CR35","doi-asserted-by":"publisher","first-page":"1655","DOI":"10.1007\/s40744-023-00602-9","volume":"10","author":"N Frede","year":"2023","unstructured":"Frede N, et al. Psoriasis and psoriatic arthritis have a major impact on quality of life and depressive symptoms: a cross-sectional study of 300 patients. Rheumatol Ther. 2023;10(6):1655\u201368.","journal-title":"Rheumatol Ther"},{"key":"1499_CR36","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.genhosppsych.2022.01.006","volume":"75","author":"TL Hedemann","year":"2022","unstructured":"Hedemann TL, et al. Associations between psoriasis and mental illness: an update for clinicians. Gen Hosp Psychiatry. 2022;75:30\u20137.","journal-title":"Gen Hosp Psychiatry"},{"issue":"1","key":"1499_CR37","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1080\/09546634.2019.1572865","volume":"31","author":"DJ Pithadia","year":"2020","unstructured":"Pithadia DJ, et al. Psoriasis-associated itch: etiology, assessment, impact, and management. J Dermatolog Treat. 2020;31(1):18\u201326.","journal-title":"J Dermatolog Treat"},{"key":"1499_CR38","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpsychores.2019.109780","volume":"124","author":"JM Martinez-Ortega","year":"2019","unstructured":"Martinez-Ortega JM, et al. Quality of life, anxiety and depressive symptoms in patients with psoriasis: a case-control study. J Psychosom Res. 2019;124: 109780.","journal-title":"J Psychosom Res"},{"issue":"2","key":"1499_CR39","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1111\/bjd.15292","volume":"177","author":"LR Khoury","year":"2017","unstructured":"Khoury LR, Skov L, Moller T. Facing the dilemma of patient-centred psoriasis care: a qualitative study identifying patient needs in dermatological outpatient clinics. Br J Dermatol. 2017;177(2):436\u201344.","journal-title":"Br J Dermatol"},{"issue":"1","key":"1499_CR40","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s12895-020-00116-9","volume":"20","author":"S Meneguin","year":"2020","unstructured":"Meneguin S, et al. Quality of life of patients living with psoriasis: a qualitative study. BMC Dermatol. 2020;20(1):22.","journal-title":"BMC Dermatol"},{"issue":"5","key":"1499_CR41","doi-asserted-by":"publisher","first-page":"341","DOI":"10.5455\/medarh.2017.71.341-346","volume":"71","author":"J Mahmutovic","year":"2017","unstructured":"Mahmutovic J, et al. Correlation between quality of life and depression among persons suffering from psoriasis. Med Arch. 2017;71(5):341\u20136.","journal-title":"Med Arch"},{"issue":"8","key":"1499_CR42","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/j.ad.2018.05.007","volume":"109","author":"MB Madrid Alvarez","year":"2018","unstructured":"Madrid Alvarez MB, et al. Measurement of the psychological impact of psoriasis on patients receiving systemic treatment. Actas Dermosifiliogr (Engl Ed). 2018;109(8):733\u201340.","journal-title":"Actas Dermosifiliogr (Engl Ed)"},{"issue":"Suppl 7","key":"1499_CR43","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1111\/jdv.18917","volume":"37","author":"P Gisondi","year":"2023","unstructured":"Gisondi P, et al. Quality of life and stigmatization in people with skin diseases in Europe: a large survey from the \u201cburden of skin diseases\u201d EADV project. J Eur Acad Dermatol Venereol. 2023;37(Suppl 7):6\u201314.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"6","key":"1499_CR44","doi-asserted-by":"publisher","first-page":"202","DOI":"10.3892\/etm.2020.9332","volume":"20","author":"I Brihan","year":"2020","unstructured":"Brihan I, et al. Implications of self-esteem in the quality of life in patients with psoriasis. Exp Ther Med. 2020;20(6):202.","journal-title":"Exp Ther Med"},{"issue":"5","key":"1499_CR45","doi-asserted-by":"publisher","first-page":"343","DOI":"10.4103\/idoj.IDOJ_503_15","volume":"8","author":"H Nazik","year":"2017","unstructured":"Nazik H, Nazik S, Gul FC. Body image, self-esteem, and quality of life in patients with psoriasis. Indian Dermatol Online J. 2017;8(5):343\u20136.","journal-title":"Indian Dermatol Online J"},{"issue":"2","key":"1499_CR46","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1007\/s13555-020-00363-1","volume":"10","author":"B Jankowiak","year":"2020","unstructured":"Jankowiak B, et al. Stigmatization and quality of life in patients with psoriasis. Dermatol Ther (Heidelb). 2020;10(2):285\u201396.","journal-title":"Dermatol Ther (Heidelb)"},{"issue":"4","key":"1499_CR47","doi-asserted-by":"publisher","first-page":"597","DOI":"10.5114\/ada.2020.93242","volume":"37","author":"B Jankowiak","year":"2020","unstructured":"Jankowiak B, et al. Relationship between self-esteem and stigmatization in psoriasis patients. Postepy Dermatol Alergol. 2020;37(4):597\u2013602.","journal-title":"Postepy Dermatol Alergol"},{"issue":"1","key":"1499_CR48","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.ad.2018.05.009","volume":"110","author":"S Gonzalez-Parra","year":"2019","unstructured":"Gonzalez-Parra S, Dauden E. Psoriasis and depression: the role of inflammation. Actas Dermosifiliogr (Engl Ed). 2019;110(1):12\u20139.","journal-title":"Actas Dermosifiliogr (Engl Ed)"},{"key":"1499_CR49","unstructured":"Adolfo G de Tiedra, et al., Transcultural adaptation of the questionnaire dermatology life quality index (DLQI): El \u00cdndice de Calidad de Vida en Dermatolog\u00eda. 1998. 89: 692\u2013700."}],"container-title":["Dermatology and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13555-025-01499-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13555-025-01499-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13555-025-01499-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,7]],"date-time":"2025-09-07T16:37:41Z","timestamp":1757263061000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13555-025-01499-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,18]]},"references-count":49,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["1499"],"URL":"https:\/\/doi.org\/10.1007\/s13555-025-01499-8","relation":{},"ISSN":["2193-8210","2190-9172"],"issn-type":[{"type":"print","value":"2193-8210"},{"type":"electronic","value":"2190-9172"}],"subject":[],"published":{"date-parts":[[2025,7,18]]},"assertion":[{"value":"18 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Esteban Daud\u00e9n has served as advisory board member and consultant, and reports grants, research support, participation in clinical trials and honorarium for speaking, for AbbVie, Abbott, Almirall, Amgen-Celgene, Johnson & Johnson\/Janssen-Cilag, Leo-Pharma, Novartis, Pfizer, MSD-Schering-Plough, Lilly, UCB, Bristol-Myers and Boehringer-Ingelheim. Isabel Belinch\u00f3n has received fees as a consultant and\/or speaker and has participated in clinical trials sponsored by the following pharmaceutical companies whose therapeutic arsenal includes drugs used to treat psoriasis: Janssen Pharmaceuticals Inc, Almirall, Lilly, AbbVie, Novartis, Celgene, Biogen, Amgen, Leo-Pharma, Pfizer-Wyeth, BMS, UCB, and MSD-Schering-Plough. Pablo Coto has served as speaker and consultant, and has participated in educational and scientific projects or clinical trials for AbbVie, Amgen, Almirall, Incyte, Leo-Pharma, UCB, and Sanofi. Pablo de la Cueva has served as a consultant, speaker and investigator for AbbVie, Almirall, BMS, Boehringer-Ingelheim, Celgene, Johnson & Johnson, LEO Pharma, Lilly, MSD, Novartis, Pfizer, Roche, Sanofi, and UCB. Isabel Cabezas and Luis Liz\u00e1n work for an independent research entity (Outcomes\u201910) that received funding from Almirall to coordinate and conduct the project. Elena Colominas-Gonz\u00e1lez, Fernando Gallardo, Jose Luis Poveda, Esther Ram\u00edrez, Sandra Ros, and Ricardo Ru\u00edz-Villaverde have nothing to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"Ethical approval for this study was obtained from the Clinical Research Ethics Committee (CREC) of Hospital La Princesa (Madrid) (Reference number: LIB 14\/2007) and complied with the Helsinki Declaration of 1975, as revised in 1983. All patients and HCP\u2019s provided informed consent for this study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}